Johnson Investment Counsel’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.41M | Sell |
100,100
-5,581
| -5% | -$146K | 0.02% | 298 |
|
|
2026
Q1 | $2.97M | Sell |
105,681
-8,460
| -7% | -$225K | 0.02% | 255 |
|
|
2025
Q4 | $2.84M | Sell |
114,141
-210
| -0.2% | -$5.3K | 0.02% | 247 |
|
|
2025
Q3 | $2.91M | Sell |
114,351
-9,647
| -8% | -$238K | 0.02% | 241 |
|
|
2025
Q2 | $3.01M | Sell |
123,998
-19,435
| -14% | -$453K | 0.03% | 224 |
|
|
2025
Q1 | $3.63M | Buy |
143,433
+33,068
| +30% | +$865K | 0.04% | 201 |
|
|
2024
Q4 | $2.93M | Sell |
110,365
-21,537
| -16% | -$584K | 0.03% | 225 |
|
|
2024
Q3 | $3.82M | Buy |
131,902
+1,439
| +1% | +$42K | 0.04% | 189 |
|
|
2024
Q2 | $3.65M | Sell |
130,463
-7,291
| -5% | -$201K | 0.04% | 184 |
|
|
2024
Q1 | $3.82M | Sell |
137,754
-6,038
| -4% | -$168K | 0.04% | 179 |
|
|
2023
Q4 | $4.14M | Sell |
143,792
-17,544
| -11% | -$530K | 0.05% | 168 |
|
|
2023
Q3 | $5.35M | Buy |
161,336
+9,863
| +7% | +$349K | 0.07% | 138 |
|
|
2023
Q2 | $5.56M | Sell |
151,473
-9,318
| -6% | -$363K | 0.07% | 138 |
|
|
2023
Q1 | $6.56M | Sell |
160,791
-44,483
| -22% | -$1.92M | 0.09% | 126 |
|
|
2022
Q4 | $10.5M | Buy |
205,274
+1,260
| +0.6% | +$60.4K | 0.14% | 99 |
|
|
2022
Q3 | $8.93M | Sell |
204,014
-7,973
| -4% | -$387K | 0.13% | 98 |
|
|
2022
Q2 | $11.1M | Buy |
211,987
+21,964
| +12% | +$1.12M | 0.16% | 93 |
|
|
2022
Q1 | $9.84M | Sell |
190,023
-6,943
| -4% | -$360K | 0.12% | 109 |
|
|
2021
Q4 | $11.6M | Sell |
196,966
-8,348
| -4% | -$414K | 0.14% | 99 |
|
|
2021
Q3 | $8.83M | Buy |
205,314
+20,510
| +11% | +$909K | 0.12% | 112 |
|
|
2021
Q2 | $7.24M | Sell |
184,804
-617
| -0.3% | -$24K | 0.1% | 115 |
|
|
2021
Q1 | $6.72M | Buy |
185,421
+3,692
| +2% | +$131K | 0.1% | 120 |
|
|
2020
Q4 | $6.69M | Sell |
181,729
-10,879
| -6% | -$399K | 0.11% | 107 |
|
|
2020
Q3 | $6.71M | Sell |
192,608
-276
| -0.1% | -$9.68K | 0.12% | 106 |
|
|
2020
Q2 | $5.98M | Sell |
192,884
-5,055
| -3% | -$172K | 0.12% | 106 |
|
|
2020
Q1 | $6.13M | Sell |
197,939
-1,292
| -0.6% | -$44K | 0.14% | 102 |
|
|
2019
Q4 | $7.41M | Sell |
199,231
-9,756
| -5% | -$348K | 0.14% | 107 |
|
|
2019
Q3 | $7.12M | Buy |
208,987
+39,533
| +23% | +$1.44M | 0.14% | 105 |
|
|
2019
Q2 | $6.96M | Buy |
169,454
+815
| +0.5% | +$32.4K | 0.14% | 108 |
|
|
2019
Q1 | $6.79M | Sell |
168,639
-8,463
| -5% | -$339K | 0.15% | 104 |
|
|
2018
Q4 | $7.33M | Buy |
177,102
+7,403
| +4% | +$307K | 0.18% | 96 |
|
|
2018
Q3 | $7.09M | Buy |
169,699
+3,896
| +2% | +$150K | 0.16% | 103 |
|
|
2018
Q2 | $5.71M | Sell |
165,803
-4,163
| -2% | -$142K | 0.14% | 107 |
|
|
2018
Q1 | $5.72M | Sell |
169,966
-190
| -0.1% | -$6.53K | 0.15% | 105 |
|
|
2017
Q4 | $5.85M | Buy |
170,156
+1,717
| +1% | +$58.5K | 0.15% | 108 |
|
|
2017
Q3 | $5.71M | Sell |
168,439
-3,073
| -2% | -$98.8K | 0.15% | 108 |
|
|
2017
Q2 | $5.46M | Buy |
171,512
+5,944
| +4% | +$187K | 0.15% | 106 |
|
|
2017
Q1 | $5.37M | Sell |
165,568
-7,742
| -4% | -$244K | 0.16% | 105 |
|
|
2016
Q4 | $5.34M | Sell |
173,310
-2,497
| -1% | -$76.2K | 0.16% | 104 |
|
|
2016
Q3 | $5.65M | Buy |
175,807
+6,075
| +4% | +$203K | 0.18% | 98 |
|
|
2016
Q2 | $5.67M | Buy |
169,732
+3,936
| +2% | +$126K | 0.19% | 97 |
|
|
2016
Q1 | $4.66M | Buy |
165,796
+4,829
| +3% | +$138K | 0.16% | 101 |
|
|
2015
Q4 | $4.93M | Buy |
160,967
+2,399
| +2% | +$75.5K | 0.17% | 97 |
|
|
2015
Q3 | $4.72M | Sell |
158,568
-8,758
| -5% | -$281K | 0.17% | 99 |
|
|
2015
Q2 | $5.32M | Buy |
167,326
+24,250
| +17% | +$790K | 0.18% | 99 |
|
|
2015
Q1 | $4.72M | Buy |
143,076
+16,925
| +13% | +$538K | 0.16% | 102 |
|
|
2014
Q4 | $3.73M | Buy |
126,151
+11,953
| +10% | +$343K | 0.12% | 118 |
|
|
2014
Q3 | $3.2M | Sell |
114,198
-4,377
| -4% | -$123K | 0.11% | 122 |
|
|
2014
Q2 | $3.34M | Sell |
118,575
-628
| -0.5% | -$17.9K | 0.12% | 107 |
|
|
2014
Q1 | $3.63M | Buy |
119,203
+14,141
| +13% | +$422K | 0.13% | 99 |
|
|
2013
Q4 | $3.05M | Buy |
105,062
+4,697
| +5% | +$137K | 0.11% | 113 |
|
|
2013
Q3 | $2.73M | Sell |
100,365
-6,610
| -6% | -$180K | 0.11% | 118 |
|
|
2013
Q2 | $2.84M | Buy |
+106,975
| New | +$2.96M | 0.12% | 111 |
|
Other funds holding PFE
Johnson Investment Counsel's PFE Position: Q2 2026 in Review
Johnson Investment Counsel reduced its Pfizer (PFE) stake by 5.3% in Q2 2026, selling an estimated $146K and leaving 100,100 shares worth $2.41M. The position accounts for 0.02% of the portfolio, ranked #298.
Johnson Investment Counsel first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.6M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Johnson Investment Counsel held 100,100 shares of Pfizer worth $2.41M as of Q2 2026.
- Johnson Investment Counsel sold 5,581 Pfizer shares in Q2 2026, an estimated $146K.
- Pfizer made up 0.02% of Johnson Investment Counsel's portfolio in Q2 2026, its #298 holding.
- Johnson Investment Counsel first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Johnson Investment Counsel's Pfizer position peaked at $11.6M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.